4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-21-088833
Options or other derivatives
- Director acquired 78,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Chanan-Khan Asher Director | 2021-06-30 | Grant or award · Stock option (right to buy) | +78,000 | 78,000 | D | ||
Loading xslF345X03/tm2120855-2_4seq1.xml…